Finance

Eye-care group Alcon expects product launches to drive 2026 sales, profitability

Published by Global Banking & Finance Review

Posted on February 25, 2026

2 min read

· Last updated: April 2, 2026

Add as preferred source on Google
Eye-care group Alcon expects product launches to drive 2026 sales, profitability
Global Banking & Finance Awards 2026 — Call for Entries

Feb 25 (Reuters) - Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates and guided for a significant expansion in its operating margin, signalling confidence that product

Alcon sees product launches boosting 2026 sales and operating margins

2026 Guidance and Profitability Drivers

Feb 25 (Reuters) - Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates and guided for a significant expansion in its operating margin, signalling confidence that product launches would drive improved profitability.

Sales Growth Forecast

The Swiss eye-care group sees constant-currency sales growth of 5% to 7%, which is roughly in line with analysts' average revenue estimate of $11.13 billion, according to LSEG data, as it bets on continued uptake of its surgical platforms and contact lenses despite tariff pressures.

Tariff and Cost Outlook

The company said tariff-related costs would be between $125 million and $175 million in 2026, net of mitigation actions.

China Market Risks

Growth in China will remain sensitive to volume‑based procurement initiatives and broader economic softness, it added.

Cataract Surgery Demand

Last year, Alcon benefited from sturdy procedural demand in cataract surgery, widely viewed as a largely non‑discretionary procedure for ageing populations. 

Unity Platform Impact

Q4 Surgical Performance

Surgical sales rose 9% to $1.55 billion in the fourth quarter, led by 21% growth in equipment following recent launches, including the Unity surgery tools platform. Consumables, a recurring revenue engine, climbed 8%.

Quarterly Margin Trend

Operating margin fell to 11.6% in the quarter, from 15.9% a year earlier, as Alcon increased spending on new product launches and absorbed higher research-and-development and tariff-related costs.

PanOptix Pro Momentum

Investor Focus into 2026

Investors are likely to focus on whether the momentum from PanOptix Pro and newer equipment platforms can sustain growth through 2026 amid supply-chain and pricing pressures.

Reporting and Editing Credits

(Reporting by Maria Rugamer in Gdansk, editing by Milla Nissi-Prussak)

Key Takeaways

  • Alcon guides 2026 constant-currency sales growth of 5%–7% and targets core margin expansion of 70–170 bps, supported by recent launches. (investor.alcon.com)
  • Management expects $125–$175M in net tariff costs in 2026, which will pressure cost of sales. (investor.alcon.com)
  • Q4 2025 Surgical revenue rose 9% to $1.55B, with equipment up 21% on Unity platform momentum. (investor.alcon.com)
  • Vision Care grew 10% in Q4, with contact lenses up 7% and ocular health up 14%. (investor.alcon.com)
  • Investors will watch if PanOptix Pro and Unity can sustain growth amid competitive and pricing pressures. (investor.alcon.com)

References

Frequently Asked Questions

What is the main topic?
Alcon issued a 2026 outlook calling for 5%–7% constant-currency sales growth and core margin expansion, underpinned by recent product launches. ([investor.alcon.com](https://investor.alcon.com/news-and-events/press-releases/news-details/2026/Alcon-Delivers-Strong-Fourth-Quarter-2025-Topline-Growth-as-New-Product-Launches-Accelerate-Sales/default.aspx?utm_source=openai))
Which products are expected to drive growth?
PanOptix Pro intraocular lenses and the Unity surgical platform are key drivers, alongside continued demand in contact lenses and ocular health. ([investor.alcon.com](https://investor.alcon.com/news-and-events/press-releases/news-details/2026/Alcon-Delivers-Strong-Fourth-Quarter-2025-Topline-Growth-as-New-Product-Launches-Accelerate-Sales/default.aspx))
How could tariffs affect results in 2026?
Alcon expects $125–$175M in net tariff costs in 2026, which could weigh on costs even as new products support growth. ([investor.alcon.com](https://investor.alcon.com/news-and-events/press-releases/news-details/2026/Alcon-Delivers-Strong-Fourth-Quarter-2025-Topline-Growth-as-New-Product-Launches-Accelerate-Sales/default.aspx?utm_source=openai))

Tags

Related Articles

More from Finance

Explore more articles in the Finance category